An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition (DDYNAMO)

November 6, 2018 updated by: Duke University
The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from dairy and other animal source proteins) with calorie restriction and low-intensity exercise on muscle quality and muscle adipose infiltration (along with bone mineral density [BMD] and a number of secondary outcomes) in frail, obese, older adults participating in a 6 month intervention. The investigators will compare these effects to those of a traditional control regimen of calorie restriction and low-intensity exercise over the same duration.

Study Overview

Detailed Description

Obese older adults (≥60 yrs) with moderate functional impairment will be randomized to 1 of 2 study arms. Outcomes to be measured at 0, 3 and 6 months are as follows: Primary outcomes- (1) Muscle Quality (MQ): muscle power (time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity) in relation to muscle mass (CT-scan) and (2) Muscle adipose infiltration (MAI) (CT-scan). Secondary outcomes- Bone Mineral Density (BMD; DXA scan) physical function (Short Physical Performance Battery (SPPB); 6 minute walk; 8-foot up and go; and 30 second chair stands; handgrip strength; body weight; fat mass; waist circumference; activity (accelerometers); mental health (sleep, depression, quality of life); and feasibility factors (adherence, protein intake, nutrition adequacy). BMD will only be accessed at 0 and 6 months.

Study Arms:

  • Weight loss plus low-intensity exercise intervention (WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, protein~0.8g/g/d. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly. One serving of dairy protein/day will be provided to WL-LoEX participants.
  • High protein weight loss plus low-intensity exercise intervention (PRO-WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, with a high proportion of high quality protein at each meal. Intakes of > 30g of protein will be achieved three times a day by subjects in this group, with all or predominantly all from animal sources (high quality) and 60-70% of animal protein from dairy foods that will be provided. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly.

Study Type

Interventional

Enrollment (Actual)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

56 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI >30;
  • SPPB score of ≥4 to <10;
  • GFR <45 mL/min

Exclusion Criteria:

  • Body weight >495 lbs. (BodPod limits);
  • estimated glomerular filtration rates (eGFR) less than 45 mL/min;
  • symptomatic cardiac disease;
  • receiving chemotherapy;
  • hemophilia;
  • presence of unstable or symptomatic life-threatening illness;
  • neurological disease or disorder causing functional impairments;
  • inability to walk,
  • dementia;
  • prescription weight loss medications;
  • use of monamine oxidase inhibitors (MAOIs); or
  • primary medical provider advises against participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: WL-LoEX
10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg). Participants will be provided one serving of dairy protein daily.
Participants will be prescribed hypo-caloric diet prescription.
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Participants in both groups will participate in chair exercises 3 times a week.
Active Comparator: Pro-WL-LoEX
Protein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy). Participants will be provided at least 8 servings of dairy protein daily.
Participants will be prescribed hypo-caloric diet prescription.
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Participants in both groups will participate in chair exercises 3 times a week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle quality
Time Frame: baseline, 3 months, 6 months
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
baseline, 3 months, 6 months
Change in muscle adipose infiltration
Time Frame: baseline, 3 months, 6 months
CT-scan
baseline, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Physical Function
Time Frame: baseline, 3 months, 6 months
short physical performance battery score
baseline, 3 months, 6 months
Change in Body weight
Time Frame: baseline, 3 months, 6 months
change in weight
baseline, 3 months, 6 months
Change in lean Body Mass
Time Frame: baseline, 3 months, 6 months
BodPod
baseline, 3 months, 6 months
Change in lean Body Mass
Time Frame: baseline, 3 months, 6 months
DEXA
baseline, 3 months, 6 months
Change in fat mass
Time Frame: baseline, 3 months, 6 months
BodPod
baseline, 3 months, 6 months
Change in fat mass
Time Frame: baseline, 3 months, 6 months
DEXA
baseline, 3 months, 6 months
Change in 6-minute walk time
Time Frame: baseline, 3 months, 6 months
6-minute walk
baseline, 3 months, 6 months
Change in 8-foot up and go time
Time Frame: baseline, 3 months, 6 months
time it takes to complete 8-foot up and go
baseline, 3 months, 6 months
Change in 30 second chair stands
Time Frame: baseline, 3 months, 6 months
number of chair stands done in 30 seconds
baseline, 3 months, 6 months
Change in dietary protein intake
Time Frame: baseline, 3 months, 6 months
3-day food record
baseline, 3 months, 6 months
Change in calorie intake
Time Frame: baseline, 3 months, 6 months
3-day food record
baseline, 3 months, 6 months
Change in Bone Mineral Density
Time Frame: Baseline and 6-months
DEXA
Baseline and 6-months
Change in sleep
Time Frame: baseline, 3 months, 6 months
Pittsburgh sleep quality index
baseline, 3 months, 6 months
Change in depression
Time Frame: baseline, 3 months, 6 months
Center for Epidemiologic Studies Depression Scale
baseline, 3 months, 6 months
Change in hand grip strength
Time Frame: baseline, 3 months, 6 months
Jamar Hand Dynamometer
baseline, 3 months, 6 months
Change in physical activity
Time Frame: baseline, 3 months, 6 months
Community Health Activities Model Program for Seniors (CHAMPS)
baseline, 3 months, 6 months
Change in physical activity
Time Frame: Baseline, 3 months, 6 months
Actigraph - accelerometer
Baseline, 3 months, 6 months
Change in quality of life
Time Frame: Baseline, 3 months, 6 months
SF-36
Baseline, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Connie Bales, PhD, RD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2015

Primary Completion (Actual)

October 15, 2018

Study Completion (Actual)

October 15, 2018

Study Registration Dates

First Submitted

May 5, 2015

First Submitted That Met QC Criteria

May 5, 2015

First Posted (Estimate)

May 7, 2015

Study Record Updates

Last Update Posted (Actual)

November 7, 2018

Last Update Submitted That Met QC Criteria

November 6, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00057509

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Weight Loss

Subscribe